Global Autoimmune Disease Diagnostics Market Size, Status and Forecast 2020-2026

    • ID: AR2947154
    • 30 July, 2020
    • Other
    • Region: Global
    • 132 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Analyzers
      • 1.4.3 Assay Kits
    • 1.5 Market by Application
      • 1.5.1 Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospitals
      • 1.5.3 Diagnostic and Research Laboratories
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Global Autoimmune Disease Diagnostics Market Perspective (2015-2026)
    • 2.2 Global Autoimmune Disease Diagnostics Growth Trends by Regions
      • 2.2.1 Autoimmune Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Autoimmune Disease Diagnostics Historic Market Share by Regions (2015-2020)
      • 2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Autoimmune Disease Diagnostics Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Autoimmune Disease Diagnostics Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Autoimmune Disease Diagnostics Players by Market Size
      • 3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2015-2020)
      • 3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Autoimmune Disease Diagnostics Market Concentration Ratio
      • 3.2.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2019
    • 3.3 Autoimmune Disease Diagnostics Key Players Head office and Area Served
    • 3.4 Key Players Autoimmune Disease Diagnostics Product Solution and Service
    • 3.5 Date of Enter into Autoimmune Disease Diagnostics Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2015-2020)
    • 4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2021-2026)

    5 Market Size by Application (2015-2026)

    • 5.1 Global Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
    • 5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 6.2 Autoimmune Disease Diagnostics Key Players in North America (2019-2020)
    • 6.3 North America Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 6.4 North America Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 7.2 Autoimmune Disease Diagnostics Key Players in Europe (2019-2020)
    • 7.3 Europe Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 7.4 Europe Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    8 China

    • 8.1 China Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 8.2 Autoimmune Disease Diagnostics Key Players in China (2019-2020)
    • 8.3 China Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 8.4 China Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 9.2 Autoimmune Disease Diagnostics Key Players in Japan (2019-2020)
    • 9.3 Japan Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 9.4 Japan Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 10.2 Autoimmune Disease Diagnostics Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    11 India

    • 11.1 India Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 11.2 Autoimmune Disease Diagnostics Key Players in India (2019-2020)
    • 11.3 India Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 11.4 India Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Autoimmune Disease Diagnostics Market Size (2015-2020)
    • 12.2 Autoimmune Disease Diagnostics Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
    • 12.4 Central & South America Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Abbott Laboratories
      • 13.1.1 Abbott Laboratories Company Details
      • 13.1.2 Abbott Laboratories Business Overview
      • 13.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
      • 13.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020))
      • 13.1.5 Abbott Laboratories Recent Development
    • 13.2 Beckman Coulter
      • 13.2.1 Beckman Coulter Company Details
      • 13.2.2 Beckman Coulter Business Overview
      • 13.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
      • 13.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.2.5 Beckman Coulter Recent Development
    • 13.3 Bio-Rad Laboratories
      • 13.3.1 Bio-Rad Laboratories Company Details
      • 13.3.2 Bio-Rad Laboratories Business Overview
      • 13.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
      • 13.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.3.5 Bio-Rad Laboratories Recent Development
    • 13.4 EUROIMMUN
      • 13.4.1 EUROIMMUN Company Details
      • 13.4.2 EUROIMMUN Business Overview
      • 13.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
      • 13.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.4.5 EUROIMMUN Recent Development
    • 13.5 Inova Diagnostics
      • 13.5.1 Inova Diagnostics Company Details
      • 13.5.2 Inova Diagnostics Business Overview
      • 13.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
      • 13.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.5.5 Inova Diagnostics Recent Development
    • 13.6 Roche Diagnostics
      • 13.6.1 Roche Diagnostics Company Details
      • 13.6.2 Roche Diagnostics Business Overview
      • 13.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
      • 13.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.6.5 Roche Diagnostics Recent Development
    • 13.7 Siemens Healthcare
      • 13.7.1 Siemens Healthcare Company Details
      • 13.7.2 Siemens Healthcare Business Overview
      • 13.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
      • 13.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.7.5 Siemens Healthcare Recent Development
    • 13.8 DiaSorin
      • 13.8.1 DiaSorin Company Details
      • 13.8.2 DiaSorin Business Overview
      • 13.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
      • 13.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.8.5 DiaSorin Recent Development
    • 13.9 ERBA Diagnostics
      • 13.9.1 ERBA Diagnostics Company Details
      • 13.9.2 ERBA Diagnostics Business Overview
      • 13.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
      • 13.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.9.5 ERBA Diagnostics Recent Development
    • 13.10 Euro Diagnostica
      • 13.10.1 Euro Diagnostica Company Details
      • 13.10.2 Euro Diagnostica Business Overview
      • 13.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
      • 13.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 13.10.5 Euro Diagnostica Recent Development
    • 13.11 Autoimmune Technologies
      • 10.11.1 Autoimmune Technologies Company Details
      • 10.11.2 Autoimmune Technologies Business Overview
      • 10.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
      • 10.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.11.5 Autoimmune Technologies Recent Development
    • 13.12 Avant Diagnostics
      • 10.12.1 Avant Diagnostics Company Details
      • 10.12.2 Avant Diagnostics Business Overview
      • 10.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.12.5 Avant Diagnostics Recent Development
    • 13.13 Exagen Diagnostics
      • 10.13.1 Exagen Diagnostics Company Details
      • 10.13.2 Exagen Diagnostics Business Overview
      • 10.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.13.5 Exagen Diagnostics Recent Development
    • 13.14 Gold Standard Diagnostics
      • 10.14.1 Gold Standard Diagnostics Company Details
      • 10.14.2 Gold Standard Diagnostics Business Overview
      • 10.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.14.5 Gold Standard Diagnostics Recent Development
    • 13.15 HOB Diagnostics
      • 10.15.1 HOB Diagnostics Company Details
      • 10.15.2 HOB Diagnostics Business Overview
      • 10.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.15.5 HOB Diagnostics Recent Development
    • 13.16 HUMAN Diagnostics
      • 10.16.1 HUMAN Diagnostics Company Details
      • 10.16.2 HUMAN Diagnostics Business Overview
      • 10.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.16.5 HUMAN Diagnostics Recent Development
    • 13.17 Immco Diagnostics
      • 10.17.1 Immco Diagnostics Company Details
      • 10.17.2 Immco Diagnostics Business Overview
      • 10.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.17.5 Immco Diagnostics Recent Development
    • 13.18 ImmunArray
      • 10.18.1 ImmunArray Company Details
      • 10.18.2 ImmunArray Business Overview
      • 10.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
      • 10.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.18.5 ImmunArray Recent Development
    • 13.19 Myriad Genetics
      • 10.19.1 Myriad Genetics Company Details
      • 10.19.2 Myriad Genetics Business Overview
      • 10.19.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
      • 10.19.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.19.5 Myriad Genetics Recent Development
    • 13.20 Omega Diagnostics
      • 10.20.1 Omega Diagnostics Company Details
      • 10.20.2 Omega Diagnostics Business Overview
      • 10.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
      • 10.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.20.5 Omega Diagnostics Recent Development
    • 13.21 ORGENTEC Diagnostika
      • 10.21.1 ORGENTEC Diagnostika Company Details
      • 10.21.2 ORGENTEC Diagnostika Business Overview
      • 10.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
      • 10.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.21.5 ORGENTEC Diagnostika Recent Development
    • 13.22 Phadia
      • 10.22.1 Phadia Company Details
      • 10.22.2 Phadia Business Overview
      • 10.22.3 Phadia Autoimmune Disease Diagnostics Introduction
      • 10.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.22.5 Phadia Recent Development
    • 13.23 Protagen
      • 10.23.1 Protagen Company Details
      • 10.23.2 Protagen Business Overview
      • 10.23.3 Protagen Autoimmune Disease Diagnostics Introduction
      • 10.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2015-2020)
      • 10.23.5 Protagen Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      Autoimmune Disease Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      The key players covered in this study
      Abbott Laboratories
      Beckman Coulter
      Bio-Rad Laboratories
      EUROIMMUN
      Inova Diagnostics
      Roche Diagnostics
      Siemens Healthcare
      DiaSorin
      ERBA Diagnostics
      Euro Diagnostica
      Autoimmune Technologies
      Avant Diagnostics
      Exagen Diagnostics
      Gold Standard Diagnostics
      HOB Diagnostics
      HUMAN Diagnostics
      Immco Diagnostics
      ImmunArray
      Myriad Genetics
      Omega Diagnostics
      ORGENTEC Diagnostika
      Phadia
      Protagen

      Market segment by Type, the product can be split into
      Analyzers
      Assay Kits
      Market segment by Application, split into
      Hospitals
      Diagnostic and Research Laboratories

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America



      Summary:
      Autoimmune Disease Diagnostics Market Research Report is about Autoimmune Disease Diagnostics Industry study. Get complete Autoimmune Disease Diagnostics market research report published after Market Study, Industrial Analysis with Trends & Statistics. Autoimmune Disease Diagnostics Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED